Subscribe to Entrepreneur for $5
Subscribe

Best Growth Stocks to Buy for December 22nd

ARCB, CC, and GEF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 22, 2021.

By
This story originally appeared on Zacks

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 22nd:

- Zacks

ArcBest Corporation ARCB: This provider of freight transportation and integrated logistics services carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.

ArcBest has a PEG ratio of 0.30 compared with 0.84 for the industry. The company possesses a Growth Score of A.

The Chemours Company CC: This provider of performance chemicals carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.

Chemours has a PEG ratio of 0.23, compared with 0.65 for the industry. The company possesses a Growth Score of A.

Greif, Inc. GEF: This provider of industrial packaging products and services carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.

Greif, Inc. Price and Consensus

Greif, Inc. Price and Consensus

Greif, Inc. price-consensus-chart | Greif, Inc. Quote

Greif has a PEG ratio of 0.93, compared with 1.65 for the industry. The company possesses a Growth Score of B.

Greif, Inc. PEG Ratio (TTM)

Greif, Inc. PEG Ratio (TTM)

Greif, Inc. peg-ratio-ttm | Greif, Inc. Quote

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.



Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Greif, Inc. (GEF): Free Stock Analysis Report

 

ArcBest Corporation (ARCB): Free Stock Analysis Report

 

The Chemours Company (CC): Free Stock Analysis Report

 

To read this article on Zacks.com click here.

 

Zacks Investment Research